{
  "ticker": "NUC",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02972382",
  "id": "02972382",
  "pages": 8,
  "price_sensitive": true,
  "date": "20250724",
  "time": "1451",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250724/pdf/06m3g9259fj03w.pdf",
  "summary": "**Quarterly Report (Appendix 4C) Summary:**  \n\n- **Revenue Highlights:**  \n  - **Group revenue**: $6.3m (Q4 FY25), up 167% pcp; FY25 total $22.8m (+110% pcp).  \n  - **Oli6\u00ae Nutritional sales**: $4.6m (Q4), up 93% pcp; ANZ retail up 32% pcp.  \n  - **Vietnam entry**: $0.6m sales (Q4), $1.6m YTD.  \n  - **Practitioner channel**: $1.7m (Q4), $8.5m YTD (post bWellness acquisition).  \n\n- **Cash Position**:  \n  - **Closing cash**: $3.6m (net operating outflow of $0.1m).  \n  - **Funding runway**: 49.0 months based on current burn rate (Item 8.5).  \n\n- **Key Developments**:  \n  - **Agency Agreement** with Brauer/H&S Brands (incremental $0.1m revenue in Q4).  \n  - **New Product (Oli6\u00ae Grow)**: $0.3m sales in Q4, $0.8m YTD.  \n\n**Material Risks/Omissions**: No debt, but reliance on sales growth (Vietnam/CBEC) and NPD for breakeven. No capital raising or material capex noted.",
  "usage": {
    "prompt_tokens": 4977,
    "completion_tokens": 310,
    "total_tokens": 5287,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-24T05:23:28.802623"
}